Evidence map›Paper›PMID 38477510›Full record

ArticleCancer medicine2024

Anatomic versus non-anatomic liver resection for hepatocellular carcinoma-A European multicentre cohort study in cirrhotic and non-cirrhotic patients.

Jasmin Zeindler, Gabriel Fridolin Hess, Maximilian von Heesen, Noa Aegerter, Cornelia Reber, Andreas Michael Schmitt, Simone Muenst, Martin Bolli, Savas Deniz Soysal, Otto Kollmar

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Hepatocellular carcinoma in patients without cirrhosis.World journal of gastroenterology · 2025
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Jasmin ZeindlerClarunis, University Centre for Gastrointestinal and Liver Diseases, Basel, Switzerland.ORCID 0000-0002-5400-7844
Gabriel Fridolin HessClarunis, University Centre for Gastrointestinal and Liver Diseases, Basel, Switzerland.ORCID 0000-0001-8644-8292
Maximilian von HeesenDepartment of General, Visceral, Vascular and Pediatric Surgery, University of Saarland, Homburg/Saar, Germany.
Noa AegerterFaculty of Medicine, University of Basel, Basel, Switzerland.
Cornelia ReberFaculty of Medicine, University of Basel, Basel, Switzerland.
Andreas Michael SchmittThe Royal Marsden NHS Foundation Trust, London, UK.ORCID 0000-0002-9568-8164
Simone MuenstInstitute of Medical Genetics and Pathology University Hospital Basel, Basel, Switzerland.
Martin BolliClarunis, University Centre for Gastrointestinal and Liver Diseases, Basel, Switzerland.
Savas Deniz SoysalClarunis, University Centre for Gastrointestinal and Liver Diseases, Basel, Switzerland.
Otto KollmarClarunis, University Centre for Gastrointestinal and Liver Diseases, Basel, Switzerland.
University Hospital of Basel · CHUniversity of Basel · CHRoyal Marsden NHS Foundation Trust · GBSaarland University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of hepatocellular carcinoma (HCC) is increasing in the western world over the past decades. As liver resection (LR) represents one of the most efficient treatment options, advantages of anatomic (ALR) versus non-anatomic liver resection (NALR) show a lack of consistent evidence. Therefore, the aim of this study was to investigate complications and survival rates after both resection types.

methodsThis is a multicentre cohort study using retrospectively and prospectively collected data. We included all patients undergoing LR for HCC between 2009 and 2020 from three specialised centres in Switzerland and Germany. Complication and survival rates after ALR versus NALR were analysed using uni- and multivariate Cox regression models.

resultsTwo hundred and ninety-eight patients were included. Median follow-up time was 52.76 months. 164/298 patients (55%) underwent ALR. Significantly more patients with cirrhosis received NALR (n = 94/134; p < 0.001). Complications according to the Clavien Dindo classification were significantly more frequent in the NALR group (p < 0.001). Liver failure occurred in 13% after ALR versus 8% after NALR (p < 0.215). Uni- and multivariate cox regression models showed no significant differences between the groups for recurrence free survival (RFS) and overall survival (OS). Furthermore, cirrhosis had no significant impact on OS and RFS.

conclusionNo significant differences on RFS and OS rates could be observed. Post-operative complications were significantly less frequent in the ALR group while liver specific complications were comparable between both groups. Subgroup analysis showed no significant influence of cirrhosis on the post-operative outcome of these patients.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsCohort StudiesHepatectomyHumansLiver CirrhosisRetrospective StudiesTreatment Outcomeanatomic liver resectioncirrhosishepatocellular carcinomaliver resectionnon-anatomic liver resectionsurgical oncology

Identifiers

PMID38477510
PMCPMC10935881
OpenAlexW4392768569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.